Latest oppositions filed by Csl Behring Gmbh

This table presents recent patent oppositions filed by Csl Behring Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3116527Method For Preparing Human Plasma ProteinsLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
EP2968434C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMA INCORPORATEDMar 28, 2018
EP1974014Oligopeptide-Free Cell Culture MediaBAXALTA GMBHJan 18, 2018

The following table provides an overview of the latest patents of Csl Behring Gmbh that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3564267Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
EP2256135Mar 13, 2019Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor1